Next, layer on the MRA such that all four drugs are initiated within 4 weeks, and only then increase the dose of each drug towards the target dose as tolerated. Yet another proposal for rapid ...

We think that most patients can get to 4 drugs in 4 weeks. It’s a catchy phrase, but it’s a nice way of framing the goal. There are several reasons for this approach.

Here are four use cases that best exemplify those already-established impacts of AI on drug discovery: 1. Target identification and mechanism-of-action (MOA) delivery [1] [2] ...

Fully profiled chemical probes are essential to support the unbiased interpretation of biological experiments necessary for rigorous preclinical target validation. We believe that by developing a ...

First, companies began using artificial intelligence (AI) to transform drug discovery. Now, they are jumping into the robotics race. With robots running labs, there can be more experiments ...

Previous analyses of new drug approvals have suggested that phenotypic screening strategies have been more productive than target-based approaches in the discovery of first-in-class small-molecule ...